Shares of Aurora Cannabis Inc. (NASDAQ:ACB – Get Free Report) traded down 5.2% during trading on Thursday . The stock traded as low as $4.33 and last traded at $4.42. 632,491 shares were traded during trading, a decline of 28% from the average session volume of 875,832 shares. The stock had previously closed at $4.66.
Analyst Ratings Changes
Several analysts recently commented on the stock. TD Securities upgraded shares of Aurora Cannabis to a “strong-buy” rating in a research report on Thursday, December 12th. TD Cowen started coverage on shares of Aurora Cannabis in a research report on Wednesday, December 11th. They issued a “buy” rating for the company.
Get Our Latest Research Report on Aurora Cannabis
Aurora Cannabis Stock Down 6.6 %
Institutional Trading of Aurora Cannabis
Hedge funds have recently bought and sold shares of the stock. Cubist Systematic Strategies LLC bought a new position in Aurora Cannabis during the 2nd quarter valued at about $50,000. Toronto Dominion Bank lifted its holdings in Aurora Cannabis by 34,356.4% during the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company’s stock valued at $88,000 after purchasing an additional 18,896 shares during the last quarter. Mackenzie Financial Corp bought a new position in Aurora Cannabis during the 2nd quarter valued at about $113,000. Tidal Investments LLC lifted its holdings in Aurora Cannabis by 2.7% during the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after purchasing an additional 34,988 shares during the last quarter. Finally, Headlands Technologies LLC lifted its holdings in Aurora Cannabis by 98.8% during the 2nd quarter. Headlands Technologies LLC now owns 74,988 shares of the company’s stock valued at $346,000 after purchasing an additional 37,269 shares during the last quarter. 47.63% of the stock is owned by institutional investors.
About Aurora Cannabis
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Recommended Stories
- Five stocks we like better than Aurora Cannabis
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Pros And Cons Of Monthly Dividend Stocks
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Why Are These Companies Considered Blue Chips?
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.